External validation of a rectal cancer outcome prediction model with a cohort of patients treated with preoperative radiochemotherapy and deep regional hyperthermia

References

• Sauer R, Becker H, Hohenberger W, et al.; German Rectal Cancer Study Group. (2004). Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–40.
   PubMed Web of Science ®Google Scholar
• Maas M, Nelemans PJ, Valentini V, et al. (2010). Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11:835–44.
   PubMed Web of Science ®Google Scholar
• Valentini V, van Stiphout RG, Lammering G, et al. (2011). Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol 29:3163–72.
   PubMed Web of Science ®Google Scholar
• Bosset JF, Collette L, Calais G, et al.; EORTC Radiotherapy Group Trial 22921. (2006). Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–23.
   PubMed Web of Science ®Google Scholar
• Gerard JP, Conroy T, Bonnetain F, et al. (2006). Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620–5.
   PubMed Web of Science ®Google Scholar
• Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. (2006). Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215–23.
   PubMed Web of Science ®Google Scholar
• Shen L, van Soest J, Wang J, et al. (2015). Validation of a rectal cancer outcome prediction model with a cohort of Chinese patients. Oncotarget 6:38327–35.
   PubMed Web of Science ®Google Scholar
• Berdov BA, Menteshashvili GZ. (1990). Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperthermia 6:881–90.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, et al.; Dutch Deep Hyperthermia Group. (2000). Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Lancet 355:1119–25.
   PubMed Web of Science ®Google Scholar
• Kakehi M, Ueda K, Mukojima T, et al. (1990). Multi-institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep-seated organs. Int J Hyperthermia 6:719–40.
   PubMed Web of Science ®Google Scholar
• De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, et al. (2009). Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev 3:CD006269.
   PubMed Web of Science ®Google Scholar
• Bruggmoser G, Bauchowitz S, Canters R, et al.; Atzelsberg Research Group; European Society for Hyperthermic Oncology. (2012). Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia: quality management in regional deep hyperthermia. Strahlenther Onkol 188:198–211.
   PubMed Web of Science ®Google Scholar
• Schroeder C, Gani C, Lamprecht U, et al. (2012). Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone. Int J Hyperthermia 28:707–14.
   PubMed Web of Science ®Google Scholar
• Schemper M, Smith TL. (1996). A note on quantifying follow-up in studies of failure time. Control Clin Trials 17:343–6.
   PubMedGoogle Scholar
• Gani C, Schroeder C, Heinrich V, et al. (2016). Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer. Int J Hyperthermia 32:187–92.
   PubMed Web of Science ®Google Scholar
• Nathanson SD, Cerra RF, Hetzel FW, et al. (1990). Changes associated with metastasis in B16-F1 melanoma cells surviving heat. Arch Surg 125:216–19.
   PubMed Web of Science ®Google Scholar
• Thrall DE, Prescott DM, Samulski TV, et al. (1996). Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas. Int J Radiat Oncol Biol Phys 34:1087–96.
   PubMed Web of Science ®Google Scholar
• Juang T, Stauffer PR, Craciunescu OA, et al. (2014). Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer. Int J Hyperthermia 30:176–83.
   PubMed Web of Science ®Google Scholar
• Sapozink MD, Joszef G, Astrahan MA, et al. (1990). Adjuvant pelvic hyperthermia in advanced cervical carcinoma. I. Feasibility, thermometry and device comparison. Int J Hyperthermia 6:985–96.
   PubMed Web of Science ®Google Scholar
• Gellermann J, Wlodarczyk W, Hildebrandt B, et al. (2005). Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. Cancer Res 65:5872–80.
   PubMed Web of Science ®Google Scholar
• Sreenivasa G, Gellermann J, Rau B, et al. (2003). Clinical use of the hyperthermia treatment planning system HyperPlan to predict effectiveness and toxicity. Int J Radiat Oncol Biol Phys 55:407–19.
   PubMed Web of Science ®Google Scholar
• Horsman MR, Overgaard J. (2007). Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol) 19:418–26.
   PubMed Web of Science ®Google Scholar
• Krawczyk PM, Eppink B, Essers J, et al. (2011). Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerases-1 inhibition. Proc Natl Acad Sci USA 108:9851–6.
   PubMed Web of Science ®Google Scholar
• Bergs JW, Krawczyk PM, Borovski T, et al. (2013). Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining. DNA Repair (Amst) 12:38–45.
   PubMed Web of Science ®Google Scholar
• Schildkopf P, Frey B, Mantel F, et al. (2010). Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells. Biochem Biophys Res Commun 391:1014–20.
   PubMed Web of Science ®Google Scholar
• Schildkopf P, Frey B, Ott OJ, et al. (2011). Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages. Radiother Oncol 101:109–15.
   PubMed Web of Science ®Google Scholar
• Lauber K, Brix N, Ernst A, et al. (2015). Targeting the heat shock response in combination with radiotherapy: sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity. Cancer Lett 368:209–29.
   PubMed Web of Science ®Google Scholar
• Eckert F, Gaipl US, Niedermann G, et al. (2017). Beyond checkpoint inhibition – immunotherapeutical strategies in combination with radiation. Clin Transl Radiat Oncol 2:29–35.
   PubMed Web of Science ®Google Scholar
• Werthmoller N, Frey B, Ruckert M, et al. (2016). Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo. Int J Hyperthermia 32:23–30.
   PubMed Web of Science ®Google Scholar
• Cunningham D, Humblet Y, Siena S, et al. (2004). Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337–45.
   PubMed Web of Science ®Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W, et al. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–42.
   PubMed Web of Science ®Google Scholar
• Garcia-Aguilar J, Chow OS, Smith DD, et al.; Timing of Rectal Cancer Response to Chemoradiation Consortium. (2015). Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol 16:957–66.
   PubMed Web of Science ®Google Scholar
• Appelt AL, Ploen J, Harling H, et al. (2015). High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol 16:919–27.
   PubMed Web of Science ®Google Scholar
• Rodel C, Graeven U, Fietkau R, et al.; German Rectal Cancer Study Group. (2015). Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 16:979–89.
   PubMed Web of Science ®Google Scholar
• Preoperative radiochemotherapy with hyperthermia for locally advanced rectal cancer (HT01/NCT02353858).
   Google Scholar
• Neoadjuvant chemoradiation with 5-FU (or capecitabine) and oxaliplatin combined with hyperthermia in rectal cancer (HyRec/NCT01716949).
   Google Scholar
• Gani C, Bonomo P, Zwirner K, et al. (2017). Organ preservation in rectal cancer – challenges and future strategies. Clin Transl Radiat Oncol 3:9–15.
   PubMed Web of Science ®Google Scholar
• Rasulov AO, Gordeyev SS, Barsukov YA, et al. (2017). Short-course preoperative radiotherapy combined with chemotherapy, delayed surgery and local hyperthermia for rectal cancer: a phase II study. Int J Hyperthermia 33:465–70.
   PubMed Web of Science ®Google Scholar